Infection Drugs Press Releases

Press Releases

Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe | PRLog
www.prlog.org | Feb 12, 2012
Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe. The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe. - PR11796726

New Reviews on Shigella and C diff at Eureka Science Magazine
www.prweb.com | Nov 3, 2011
The Online Science Magazine publishes daily reviews on popular topics within the biological sciences. The latest inclusions cover two infectious bacteria harmful to humans. Shigella is a bacteria that can cause dysentery and C diff (Clostridium difficile) can cause severe diarrhea.

Flu vaccines at work could save companies up to £11.6 billion each year
www.prleap.com | Sep 30, 2011
Introducing Flu vaccines at work could cut staff sickness to save businesses a combined £11.6 billion each year. That's £476 per employee, according to a recent survey.

Genetic Technology Alert. Pharmacogenetic Test for Drug Metabolizing Enzyme; Rapid Synthesis of
www.frost.com | Apr 8, 2011
This issue profiles a pharmacogenetic test for drug metabolizing enzyme, rapid synthesis of closed linear DNA for DNA vaccines, and intracellular idenitification of nucleic acid delivery vehicles through DNA display. Strategic partnership details and some important patents have also been included.

Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of
www.abbott.com | Apr 4, 2011
Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C

Antibiotic Drug Development | Woodcock Defends FDA as Experts Question Agency Regarding Antibiotics
www.pharmamanufacturing.com | Jun 11, 2010
Experts expressed concerns over what they see as inconsistent guidance from FDA regarding the development of new antibiotics.

Inovio Biomedical Named “Best Early Stage Biotech” Company at World Vaccine Congress 2010 - News
www.pharmiweb.com | Apr 21, 2010
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company was awarded a Vaccine Industry Excellence Award in the category of “Best Early Stage Biotech” by a panel of

The Future of the Biologicals Market: Market overview, innovations and company profiles now
www.environmental-expert.com | Apr 13, 2010
Dallas, ReportsandReports Announce it Will Carry the The Future of the Biologicals Market: Market overview, innovations and company profiles Market Research Rep

Medical News: DayQuil Packs Recalled for Lack of Childproofing - in Product Alert, Devices and
www.medpagetoday.com | Dec 21, 2009
Procter & Gamble voluntarily has recalled one of its cold and flu medications because packages of blister packs labeled as child-resistant don't have child-resistant backing.

The ABB Group: ABB and Fortum to develop large-scale smart grid for sustainable city project
www.abb.com | Nov 13, 2009
Zurich, Switzerland, Nov.13, 2009 – ABB, the leading power and automation technology group, will work on a joint development project with the Nordic utility Fortum to design and install a large-scale smart grid in a new district of the city of Stockholm.